ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiBardino, D. J.
Right arrow Articles by Awad, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiBardino, D. J.
Right arrow Articles by Awad, S. S.
Related Collections
Right arrow Pleura

Ann Thorac Surg 2002;74:257-258
© 2002 The Society of Thoracic Surgeons


Case report

Acute respiratory failure after pleurodesis with doxycycline

Daniel J. DiBardino, MD*a, Jason M. Vanatta, MDa, Shawn P. Fagan, MDa, Samir S. Awad, MDa

a The Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA

Accepted for publication October 20, 2001.

* Address reprint requests to Dr DiBardino, 6540 Bellows Lane, Apartment 603, Houston, TX 77030 USA
e-mail: ab9088{at}hotmail.com


    Abstract
 Top
 Abstract
 Introduction
 Comment
 References
 
Bedside pleurodesis through a tube thoracostomy has been shown to be effective treatment of malignant pleural effusion and pneumothorax with persistent air leak. A variety of agents can be used, and each has been shown to produce rare but potentially serious complications. We report a case of sudden, severe respiratory failure in a 42-year-old man after pleurodesis with 300 mg of doxycycline. His response was consistent with an anaphylactic reaction. After intubation, mechanical ventilation and nebulizer treatments, he rapidly recovered to baseline. On the basis of this report and a review of the literature, we believe that doxycycline may not be an innocuous agent for bedside pleurodesis and that such procedures warrant a monitored setting.


    Introduction
 Top
 Abstract
 Introduction
 Comment
 References
 
Numerous studies have documented the overall effectiveness and safety of chemical pleurodesis with a variety of agents. Because tetracycline is no longer available, current options include talc, doxycycline, and bleomycin sulfate. Most large series of chemical pleurodesis using these agents report only minor complications such as transient fever and pain. We report a case of acute, severe respiratory failure immediately after bedside pleurodesis with doxycycline.

A 42-year-old man with a history of alcoholism was admitted to the Houston Veterans Affairs Medical Center with a diagnosis of rhabdomyolysis. A multiloculated right-sided empyema developed, and on hospital day 9, the patient underwent open right-sided thoracotomy and decortication. Two chest tubes were left in place, and a third chest tube was placed in the week that followed the operation for persistent air leak. Bedside pleurodesis with 100 mL of 50% dextrose was attempted on hospital day 35 but was ineffective.

On hospital day 44, bedside pleurodesis was attempted with 300 mg of doxycycline mixed in 125 mL of normal saline solution and 250 mL of 5% dextrose in water. Immediately after the introduction of this agent into the chest, the patient became severely hypoxic, tachycardiac, and diaphoretic with a heart rate of 137 beats per minute, a respiratory rate of 40 to 50 breaths/min, an arterial oxygen saturation of 25% to 32%, and palpable pulses. Although difficult to assess secondary to severe respiratory distress, the patient did not complain of pain. Major findings on examination included minimal airway movement in the bilateral lung fields at auscultation and severe cyanosis.

During emergent endotracheal intubation, a blood gas study revealed the following: pH 6.98; oxygen tension, 35 mm Hg; and carbon dioxide tension, 59 mm Hg. The patient was placed on a ventilator. Initial peak airway pressures were 50 to 65 mm Hg on the following ventilator settings: synchronized intermittent mandatory ventilation, 10 breaths/min; tidal volume, 600 mL; pressure support, 10 mm Hg; positive end-expiratory pressure, 5 mm Hg; and inspired oxygen fraction, 100%. The patient responded favorably to nebulizer treatments with albuterol and Atrovent (ipratropium bromide) (0.5 µm each), and vital signs revealed a heart rate of 141 beats per minute, a respiratory rate of 24 breaths/min, and a blood pressure of 178/98 mm Hg. Chest roentgenogram revealed no pneumothorax, infiltrate, or consolidation. Bronchoscopy was performed on arrival in the intensive care unit and revealed no abnormalities. The condition of the patient improved with a decrease in peak airway pressures to 25 mm Hg at 3 hours after intubation. The patient was extubated the following morning with no difficulty.


    Comment
 Top
 Abstract
 Introduction
 Comment
 References
 
Although talc is regarded as the most effective agent for pleurodesis, there have been consistent reports of a syndrome similar to adult respiratory distress syndrome occurring after its use [1, 2]. At least one fatality has been attributed to this complication. Other less frequent complications including isolated hypoxemia, hypotension, cardiac arrhythmia, and empyema have been noted [2]. Reports such as these have left informed surgeons increasingly concerned about the safety of talc pleurodesis, and the effectiveness and the safety of other agents have been investigated.

A prospective, randomized trial [3] concluded that bleomycin is as effective as talc, but the agent is extremely costly and there is at least one report of adult respiratory distress syndrome and subsequent death after bleomycin pleurodesis [4]. Problems with tetracycline analogues include the requirement of multiple applications and the side effects of being well absorbed into the circulation, even achieving therapeutic serum levels after injection into the pleural space [5]. After pleurodesis with tetracycline, systemic absorption has led to acute renal failure at least once [5]. Reports of serious adverse effects after intrapleural doxycycline administration are absent from the literature. Fever after pleurodesis with doxycycline in humans and hepatotoxicity in the form of elevated transaminases has occurred in animal models [6].

Our patient appears to have had a severe anaphylactic reaction to the antibiotic used for pleurodesis. The acute onset of respiratory failure, the lack of airway movement on examination, the high initial mean airway pressures on the ventilator, and the response to nebulizers support this conclusion. The patient was noted to have a large air leak prior to the procedure, and even though it is possible that the doxycycline gained access to the bronchial mucosa, thereby increasing the severity of the reactive airway response, the patient did not cough up fluid and was considered to have normal mucosa on broncoscopy.

Bedside pleurodesis is an effective method for the control of malignant pleural effusions and persistent pneumothorax. Although the incidence appears to be low, this procedure can result in serious complications that vary according to the agent used. We suggest that bedside pleurodesis be performed in a monitored setting and under the direction of a surgeon so that rare but potentially serious complications can be addressed rapidly and effectively.


    References
 Top
 Abstract
 Introduction
 Comment
 References
 

  1. Rehse D.H., Aye R.W., Florence M.G. Respiratory failure following talc pleurodesis. Am J Surg 1999;177:437-440.[Medline]
  2. Kennedy L., Rusch V.W., Strange C., et al. Pleurodesis using talc slurry. Chest 1994;106:342-346.[Abstract/Free Full Text]
  3. Zimmer P.W., Hill M., Casey K., Harvey E., Low D.E. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 1997;112:430-439.[Abstract/Free Full Text]
  4. Audu P.B., Sing R.F., Mette S.A., Fallahnejhad M. Fatal diffuse alveolar injury following use of intrapleural bleomycin. Chest 1993;103:1638.
  5. Smythe W.R., Bavaria J.E. Tetracycline pleurodesis—associated acute renal failure. Chest 1993;104:1274-1276.[Abstract/Free Full Text]
  6. Mitchem R.E., Herndon B.L., Fiorella R.M., Molteni A., Battie C.N., Reisz G.R. Pleurodesis by autologous blood, doxycycline, and talc in a rabbit model. Ann Thorac Surg 1999;67:917-921.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
ChestHome page
Y. Aelony and R. Laniado-Laboren
Talc Pleurodesis vs Iodopovidone
Chest, April 1, 2003; 123(4): 1318 - 1319.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiBardino, D. J.
Right arrow Articles by Awad, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiBardino, D. J.
Right arrow Articles by Awad, S. S.
Related Collections
Right arrow Pleura


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS